Scott Sherman, co-founder of the Transformative Action Institute in California, spoke on 'Teaching to Transform the World: An Innovative Approach to Education,' Oct. 26.
Literally digging up the dirt, Cornell researchers have found that burgeoning deer populations forever alters a forest’s natural future by disrupting the soil’s seed banks.
Three government professors described what they expected from Donald Trump's foreign policy approach Nov. 10 at the weekly lecture of the Reppy Institute for Peace and Conflict Studies.
New York, NY (August 20, 2003) -- Surgeons at New York Weill Cornell medical center performed the world's first gene therapy for Parkinson's disease on a 55-year-old New York man on Monday, August 18. The historic surgery, which also marked the first-ever in vivo gene therapy in the brain for an adult neurological disease, was part of a phase I clinical trial approved by the Food and Drug Administration in October 2002. The five-hour procedure was performed by Dr. Michael G. Kaplitt, Director of Stereotactic and Functional Neurosurgery at NewYork-Presbyterian Hospital and Assistant Professor of Neurological Surgery at Weill Cornell Medical College. The patient is recovering normally and is expected to return home today, just two days after the surgery was performed."Monday's surgery represents the realization of nearly 15 years of research in this area," said Dr. Kaplitt. "The goal of our gene therapy approach is to 're-set' a specific group of cells that have become overactive in an affected part of the brain, causing the impaired movements associated with Parkinson's disease. We hope that this trial, which is the first of its kind, will prove to be a safe treatment to allow gene therapy to move forward for Parkinson's disease and other brain disorders."
James VanEe, director of information technology for the Institute for Biotechnology and Life Science Technologies, was elected co-chair of the Cornell Computing Directors for a two-year term. (Sept. 29, 2008)
The Cornell Board of Trustees recently elected three new trustee fellows and re-elected three at-large trustees, one trustee from the field of agriculture and two trustee fellows.
Jules Kroll '63, founder of Kroll Inc., the investigative firm that located Saddam Hussein's riches hidden abroad, spoke on campus Oct. 21 about fighting international corruption. (Oct. 23, 2008)
A public enemy has infiltrated the nation's borders. Taken captive in Fulton, N.Y., and identified by a Cornell expert, the adult female alien is the only one of its kind ever discovered in eastern United States.
Poet, novelist and short-story writer Robert Morgan, the Kappa Alpha Professor of English at Cornell, will receive an Academy Award in Literature from the American Academy of Arts and Letters May 16. (April 19, 2007)